Skip to main content

ANTI-HLA-B27 ANTIBODY CLONE HLA.ABC.M3 FITC CONJUGATED (C15-1889-480)

Catalog No.
C15-1889-480
Mfr. No.
MAB1286-I-100UG
Mfr. Name
Sigma-Aldrich
Qty/UOM
1
UOM
EA
Price: $804.57
List Price: $893.97

General description Most eukaryotic genes are expressed as pre-mRNAs that are converted to mRNA by splicing. In this process noncoding sequences (introns) are removed, and coding sequences (exons) are ligated together.

Enjoy exclusive benefits including discounted pricing on orders by contacting our Sales Executives to open an account. Contact Us

Adding to cart… The item has been added

General description

Most eukaryotic genes are expressed as pre-mRNAs that are converted to mRNA by splicing. In this process noncoding sequences (introns) are removed, and coding sequences (exons) are ligated together. Some exons are known to be constitutively spliced and are present in every mRNA produced from a given pre-mRNA. However, many are alternatively spliced to generate variable forms of mRNA from a single pre-mRNA species. Nuclear pre-mRNA splicing is catalyzed by the spliceosome that is a multi-megadalton ribonucleoprotein (RNP) complex. It removes introns from nuclear pre-mRNA. The conformation and composition of spliceosome is shown to be dynamic, which is critical for its high degree of accuracy and flexibility. In most eukaryotes two unique spliceosomes have been described: the U2 -dependent spliceosome that catalyzes the removal of U2-type of introns and the U12-dependent spliceosome that is present only in a subset of eukaryotes and splices U12-type of intron. Introns are removed by two consecutive transesterification reactions. In the first reaction the 2 OH group of the branch adenosine of the intron carries out a nucleophilic attack on the 5 ss, which results in cleavage at this site and ligation of the 5 end of the intron to the branch adenosine, forming a lariat structure. In the second reaction, the 3 ss is attacked by the 3 OH group of the 5 exon, which leads to the ligation of the 5 and 3 exons forming the mRNA, and release of the intron. (Ref.: Matera, AG., and Wang, Z. (2014). Nat. Rev. Mol. Cell Biol. 15(2); 108-121; Will, CL., and Luhrmann, R. (2011). Cold Spring Harb. Perspect. Biol. 3(7); a003707; Patel, AA., and Steitz, JA. (2003). Nat. Rev. Mol. Cell Biol. 4(12); 960-970).

Specificity

Clone 780-3 is a mouse monoclonal antibody that detects human Nuclear spliceosomes.

Immunogen

Nuclear preparation from U266 human myeloma cells.

Application

Quality Control Testing

Evaluated by Flow Cytometry in permeabilized HeLa cells.

Flow Cytometry Analysis: 2 μg of this antibody detected Nuclear Spliceosomes in one million permeabilized HeLa cells.

Tested Applications

Flow Cytometry Analysis: A representative lot detected Nuclear Spliceosomes in Flow Cytometry applications (Clevenger, C.V., et al. (1985). Cytometry. 6(3): 208-14; Bauer, K.D., et al. (1986). Cancer Res. 46(5): 2428-34; Clevenger, C.V., et al. (1987). Cytometry. 8(3): 280-6).

Immunofluorescence Analysis: A representative lot detected Nuclear Spliceosomes in Immunofluorescence applications (Clevenger, C.V., et al. (1984). J Histochem Cytochem. 32(7): 757-65; Clevenger, C.V., et al. (1985). Cytometry. 6(3): 208-14; Bauer, K.D., et al. (1986). Cancer Res. 46(5): 2428-34; Clevenger, C.V., et al. (1987). Cytometry. 8(3):280-6; Clevenger, C.V., et al. (1987). Cytometry. 8(3): 280-6).

Western Blotting Analysis: A representative lot detected Nuclear Spliceosomes in Western Blotting applications (Clevenger, C.V., et al. (1987). Cytometry. 8(3): 280-6; Kumar, P., et al. (2012). PLoS One. 7(8): e42712).

Electron Microscopy: A representative lot detected Nuclear Spliceosomes in Electron Microscopy applications (Clevenger, C.V., et al. (1984). J Histochem Cytochem. 32(7): 757-65; Bauer, K.D., et al. (1986). Cancer Res. 46(5): 2428-34; Clevenger, C.V., et al. (1987). Cytometry. 8(3): 280-6).

Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user

Anti-Nuclear Spliceosomes, clone 780-3, Cat. No. MAB1286-I, is a mouse monoclonal antibody that detects Nuclear spliceosomes and is tested for use in Electron Microscopy, Flow Cytometry, Immunofluorescence, and Western Blotting.

Physical form

Purified mouse monoclonal antibody IgM in PBS without preservatives.

Storage and Stability

Store at -10°C to -25°C. Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance.

Other Notes

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

UPC:
42292106
Condition:
New
Availability:
3-5 Days
Weight:
1.00 Ounces
HazmatClass:
No
MPN:
MAB1286-I-100UG

Cenmed Satisfaction Guarantee
Cenmed Satisfaction Guarantee

At Cenmed, your confidence and satisfaction are paramount. We guarantee the quality and reliability of our extensive range of clinical and laboratory supplies. If you're not completely satisfied with your purchase, we offer a straightforward return process and dedicated support to resolve your concerns promptly. Our commitment ensures that you can order with confidence, knowing that Cenmed is dedicated to superior service and customer satisfaction. Trust us to meet your needs with every order, backed by our promise of excellence. Learn more in Help & FAQs.

Testimonial
"Cenmed provides me access to the same products/services normally reserved for much larger labs than mine. I was presently surprised by their product offering."

LAB DIRECTOR

Testimonial
"We utilized Cenmed's capabilities for a variety of projects around the world. They are a valued partner and supplier."

PHARMACEUTICAL SUPPLY CHAIN LEADER

Testimonial
"The reps are very good at finding products for customers in this period of supply chain issues."

SCOTT BEHMAN

Testimonial
"Your customer service has been excellent and makes me excited about purchasing with Cenmed in the future!!"

PROCUREMENT + BILLING COORDINATOR AT PHARMA.